Also known as: MB, methylthioninium chloride, low-dose methylene blue
Latest evidence update: 2026-05-30
Strongest in Consistency (95). Held back by Replication (59).
Solid mix of RCTs with some methodological gaps.
Good cross-study replication, some imprecision.
Thousands of participants across the literature.
Studies agree on direction of effect.
Most studies are recent (last 2-3 years).
No quantified outcomes yet. Once we have studies with measurable endpoints, you will see per-outcome magnitude here.
Recommended: Researched low doses: 0.5–4 mg/kg in animals; nootropic users self-dose 0.5–4 mg, but this is unvalidated
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.